Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Nathan Spear, Ph.D.
Associate Director
Teva Pharmaceuticals, Inc.
Poster(s):
(T1030-01-06) Generic ADA Method Development for Preclinical Study
Tuesday, November 11, 2025
10:30 AM - 11:30 AM
CT
(M1030-01-07) Validation of Anti-Drug Antibody Assay for Multi-Domain Biologics for Human Clinical Studies
Monday, November 10, 2025
10:30 AM - 11:30 AM
CT